![]() |
市场调查报告书
商品编码
1451725
RFID 血液冰箱和冷冻库市场报告(按类型(RFID 冰箱、RFID 冰柜)、应用(医院和诊断中心、血库等)和地区)2024-2032 年RFID Blood Refrigerators and Freezers Market Report by Types (RFID Refrigerators, RFID Freezers), Applications (Hospitals and Diagnostic Centers, Blood Banks, and Others), and Region 2024-2032 |
2023年,全球RFID血液冰箱和冰柜市场规模达到2.914亿美元。展望未来, IMARC Group预计到2032年市场规模将达到9.718亿美元,2024-2032年复合年增长率(CAGR)为13.89%。
无线射频识别(RFID)血液冰箱和冰柜是指先进的温控储存系统,用于收集和安全保存各种试剂和血液成分,包括血浆衍生物和红血球(RBC)。它们包括互连管道、毛细管、冷凝器、膨胀器、蒸发器、电动压缩机和有助于调节冰箱温度的恆温器。一些先进模型还包括配置、压缩机、马达和紧急电源系统,以在波动期间提供能量备用。 RFID 血液冰箱和冰柜可以即时追踪关键的血小板成分及其状况,并保持产品品质符合食品药物管理局 (FDA) 法规。除此之外,它们还聪明、使用安全且可靠,有助于最大限度地减少技术错误并提高营运效率。因此,医院和诊断中心使用 RFID 血液冰箱和冷冻库来储存血液,以用于测试、储存、运输和输血目的。
包括白血病、地中海贫血和血友病在内的各种慢性疾病的盛行率不断上升,以及手术后失血发生率的上升,主要推动了市场的成长。与此一致的是,医院环境中血库对获取血浆、样本和血小板以进行实验和评估细胞功能的需求不断增加,这促进了市场上的产品需求。此外,具有由耐腐蚀钢和手柄组成的抽屉架的先进血液冰箱和冰柜的出现也是另一个促进增长的因素。此类产品由身份证夹组成,可以储存过量的血管并在不拆除整个架子的情况下取出血管。此外,政府和非政府组织(NGO)越来越多地进行倡议和宣传活动,教育大众了解捐血的好处和误解,这有利于市场的成长。除此之外,医疗保健基础设施的显着改善、持续的研发(R&D)活动以及持续的产品增强和多样化正在积极刺激市场成长。
The global RFID blood refrigerators and freezers market size reached US$ 291.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 971.8 Million by 2032, exhibiting a growth rate (CAGR) of 13.89% during 2024-2032.
Radio frequency identification (RFID) blood refrigerators and freezers refer to advanced temperature-controlled storage systems that collect and safely preserve various reagents and blood components, including plasma derivatives and red blood cells (RBCs). They encompass interconnected tubing, a capillary tube, a condenser, expansion, an evaporator, electrically powered compressors, and a thermostat that helps regulate refrigerator temperature. Some advanced models further comprise configurations, compressors, motors, and emergency power systems to provide energy backup during fluctuations. RFID blood refrigerators and freezers allow real-time tracking of critical platelet components and their conditions and maintain the product quality to comply with food and drug administration (FDA) regulations. Apart from this, they are intelligent, safe to use, and reliable and aid in minimizing technical errors and increasing operational efficiency. As a result, RFID blood refrigerators and freezers are used by hospitals and diagnostic centers to store blood for testing, storing, transporting, and transfusion purposes.
The increasing prevalence of various chronic diseases, including leukemia, thalassemia, and hemophilia, and the rising incidences of blood loss post-surgical procedures are primarily driving the market growth. In line with this, the escalating need for blood banks in hospital settings to obtain plasma, samples, and platelets for conducting experiments and assessing cell functions is facilitating the product demand in the market. Additionally, the advent of advanced blood refrigerators and freezers with drawer racks composed of corrosion-resistant steel and handles is acting as another growth-inducing factor. Such products consist of identification cardholders, and they enable the storage of blood tubes in excessive amounts and their retrieval without the removal of the entire rack. Moreover, increasing initiatives and awareness programs by governments and non-governmental organizations (NGOs) toward educating the masses on the benefits and misconceptions of blood donation are favoring the market growth. Apart from this, significant improvements in the healthcare infrastructure, ongoing research and development (R&D) activities, and continuous product enhancements and diversification are positively stimulating the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global RFID blood refrigerators and freezers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on types and applications.
RFID Refrigerators
RFID Freezers
Hospitals and Diagnostic Centers
Blood Banks
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Angelantoni Life Science Srl, Biomed Global, Cardinal Health Inc., IQM AS, MedSella (MedFlow Clinical Ltd.), Qingdao Haier Biomedical Co Ltd., Rollex Group Australia PTY Ltd., SATO Vicinity Pty Ltd. (SATO Holdings Corporation), Spacecode Technologies, Terso Solutions Inc. (Promega Corporation), Thalheimer Kuhlung GmbH & Co KG and Venture Research Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.